Dr Andrew Pierce
Lecturer (Teaching & Research)
Affiliations
Contact info
Location: Brambell, Room 412
Email: a.pierce@bangor.ac.uk
Current Position: Lecturer, Medical and Health Sciences
Other external Positions: Honorary Lecturer, Division of Cancer Sciences, The University of Manchester
- Article › Research › Peer-reviewed
-
Generation of a conditionally immortalized myeloid progenitor cell line requiring the presence of both interleukin-3 and stem cell factor to survive and proliferate.
C, L., CA, E., E, S., A, P., R, M. & AD, W., 3 Sept 2003, In: British Journal of Haematology. 122, 6, p. 985-995Research output: Contribution to journal › Article › peer-review
- Published
Global effects of BCR/ABL and TEL/PDGFRbeta expression on the proteome and phosphoproteome: identification of the Rho pathway as a target of BCR/ABL.
RD, U., DW, S., Y, L., A, P., DG, G. & AD, W., Feb 2005, In: Journal of Biological Chemistry. 280, 8, p. 6316-6326Research output: Contribution to journal › Article › peer-review
- Published
HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block
Maiques-Diaz, A., Nicosia, L., Basma, N. J., Romero-Camarero, I., Camera, F., Spencer, G. J., Amaral, F. M. R., Simeoni, F., Wingelhofer, B., Williamson, A. J. K., Pierce, A., Whetton, A. D. & Somervaille, T. C. P., 28 Oct 2022, In: Oncogene. 41, 44, p. 4841-4854 14 p.Research output: Contribution to journal › Article › peer-review
-
Haemopoietic growth factors and leukaemogenesis.
Pierce, A. & AD, W., 1 May 1997, In: Biochemical Society Transactions. 25, 2, p. 366-370Research output: Contribution to journal › Article › peer-review
Identification of curaxin as a potential new therapeutic for JAK2 V617F mutant patients
Pearson, S., Blance, R., Yan, F., Hsieh, Y-C., Geary, B., Amaral, F. M. R., Somervaille, T. C. P., Kirschner, K., Whetton, A. D. & Pierce, A., 30 May 2023, In: PLoS ONE. 18, 5, 16 p., 0286412.Research output: Contribution to journal › Article › peer-review
-
Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors.
CA, E., S, A., A, P. & AD, W., 1 Nov 2002, In: Blood. 100, 9, p. 3164-3174Research output: Contribution to journal › Article › peer-review
- Published
Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia
Alanazi, B., Munje, C. R., Rastogi, N., Williamson, A. J. K., Taylor, S., Hole, P. S., Hodges, M., Doyle, M., Baker, S., Gilkes, A. F., Knapper, S., Pierce, A., Whetton, A. D., Darley, R. L. & Tonks, A., 2020, In: Leukemia. 34, 2, p. 427-440 14 p.Research output: Contribution to journal › Article › peer-review
-
Lysophospholipids synergistically promote primitive hematopoietic cell chemotaxis via a mechanism involving Vav 1.
AD, W., Y, L., A, P., L, C. & E, S., 15 Oct 2003, In: Blood. 102, 8, p. 2798-2802Research output: Contribution to journal › Article › peer-review
-
MPL W515L expression induces TGFβ secretion and leads to an increase in chemokinesis via phosphorylation of THOC5
AD, W., NC, A., S, P., E, J., L, Z., R, B., AC, K., A, N., S, T., AJ, W. & A, P., 2016, In: Oncotarget.Research output: Contribution to journal › Article › peer-review
- Published
Macrophage inflammatory protein-1 alpha receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia.
RC, C., GS, L., PJ, O-L., A, P. & AD, W., 1 Dec 1995, In: Blood. 86, 11, p. 4270-4277Research output: Contribution to journal › Article › peer-review